We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Rapid Diagnostic Platform Delivers Up To 30 Results from Single Drop of Body Fluid within 15 Minutes

By HospiMedica International staff writers
Posted on 18 Jan 2023
Print article
ALiA platform delivers multiple results with minimal drop of sample in 15 minutes at POC (Photo courtesy of ALiA BioTech) Crop Article Image
ALiA platform delivers multiple results with minimal drop of sample in 15 minutes at POC (Photo courtesy of ALiA BioTech) Crop Article Image

Thanks to the COVID-19 pandemic, the point-of-care testing (POCT) market is expected to double in size as compared to the pre-pandemic levels. Multiplexing remains the key technology differentiator in this growing field. By increasing the number of simultaneous assays, it becomes possible to identify the right biomarker, and consequently lower the cost and time needed to control a potential outbreak. Now, a next-generation rapid diagnostic platform that is capable of conducting multiplex testing in a single biochip within 15 minutes could become a game changer in the POCT market.

ALiA BioTech’s (Hong Kong) Lab-on-Chip platform is a patented POCT that is capable of delivering up to 30 results from a single drop of body fluid, including blood, serum, swab, or urine. ALiA has completed the R&D of its proprietary microfluidic and microarray technologies, and now aims to scale up the manufacturing of multiplex products for different disease panels. ALiA analyzer and its biochip panels for respiratory infection and tropical fever have been granted the CE marking, with the accredited ISO 13485 medical device quality management system. The company is in the process of securing regulatory approval in other regions, including the U.S., mainland China and Southeast Asia, and will enter into global strategic partnerships for developing biochips for various disease panels.

“A single test on our platform gives the fast track and accurate answer,” said Kelvin Chiu, CEO of ALiA BioTech. “Over the next five to 10 years, we shall develop more multiplex diseases panels and complete clinical trials and regulatory approval processes so that we can introduce more real-time rapid diagnostic panels that are critical to rescuing lives.”

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Transvaginal Tube
LiNA McCartney Tube

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.